Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy.
about
Bacteria-human somatic cell lateral gene transfer is enriched in cancer samplesAnimal models of hemophiliaGene therapy for hemophiliaLiver-targeted gene therapy: Approaches and challengesUltrasound-targeted hepatic delivery of factor IX in hemophiliac mice.Hybrid lentivirus-phiC31-int-NLS vector allows site-specific recombination in murine and human cells but induces DNA damage.Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells.Establishment of stable reporter expression for in vivo imaging of nuclear factor-κB activation in mouse liver.Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity.Bacteriophage recombination systems and biotechnical applications.Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system.PhiC31 integrase-mediated genomic integration and stable gene expression in the mouse mammary gland after gene electrotransfer.Fast identification of reliable hosts for targeted cell line development from a limited-genome screening using combined φC31 integrase and CRE-Lox technologies.Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA.Translational Advances of Hydrofection by Hydrodynamic Injection.
P2860
Q21090158-AA8D7500-5F3E-4127-96D3-BBA5FC07B3DEQ27012571-99F50ECC-F85E-475F-A356-66B74382001BQ28081911-C4D2F973-222D-42D8-86DA-72D82802D030Q28085748-219B3A59-F653-4F05-AAEC-44D684FEAB3BQ30381138-ACAD4628-5F02-4FBF-A790-C545F056897CQ33794201-6346CD40-9AEB-4708-AA81-1C757608F2E4Q35159846-CCA6AD17-FCED-45EE-B4BA-7ABEE1203DADQ37344828-63875B08-1BB6-4AAF-9AE9-0EB30BF3B971Q37684882-3B7237CB-C0F7-4528-9F4F-199688426F31Q38179994-D3AD93DF-FEFB-4EAD-9CDE-2B85E20C00E3Q38892183-4B8D711F-F68C-43A8-8DF6-9F195F414884Q39052129-64E66FFB-7483-4217-AD25-54C43B089FF8Q39113686-4363BD97-3427-41DF-BDD1-376B6766CFCCQ41831020-0B57B17C-86BF-44CE-A6B4-7F3EF31BD567Q51730568-7381E367-6352-43FB-87E1-BC91610E4DC7
P2860
Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Long-term phenotypic correctio ...... tegrase-mediated gene therapy.
@en
Long-term phenotypic correctio ...... tegrase-mediated gene therapy.
@nl
type
label
Long-term phenotypic correctio ...... tegrase-mediated gene therapy.
@en
Long-term phenotypic correctio ...... tegrase-mediated gene therapy.
@nl
prefLabel
Long-term phenotypic correctio ...... tegrase-mediated gene therapy.
@en
Long-term phenotypic correctio ...... tegrase-mediated gene therapy.
@nl
P2093
P2860
P356
P1433
P1476
Long-term phenotypic correctio ...... tegrase-mediated gene therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2011.31
P577
2011-03-17T00:00:00Z
P5875
P6179
1005123007